|
Status |
Public on Oct 31, 2016 |
Title |
AQ85 |
Sample type |
RNA |
|
|
Source name |
ovarian cancer
|
Organism |
Homo sapiens |
Characteristics |
tissue: primary ovarian tumor age: 73.8040503557745 histology: 3 Stage: III grading: G3 dekulking: mRD ttr_time: 4.63815789473684 ttr_status: 1 os_time: 64.60526316 os_status: 1
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted with QIAGEN FFPE RNeasy mini kit in accordance with the prescribed protocol provided with the kit.
|
Label |
Cy3
|
Label protocol |
Total RNA from each sample was labeled according to the manufacturers recommendations.
|
|
|
Hybridization protocol |
Standard Agilent hybridization protocol
|
Scan protocol |
Standard Agilent scanning protocol; raw data were generated using the Feature Extraction Software v10.7.3.1 (Agilent Technologies)
|
Data processing |
The data were processed and quantile normalised using AgiMicroRna R package (Lopez-Romero P BMC Genomics. 2011;12:64)
|
|
|
Submission date |
Sep 29, 2015 |
Last update date |
Oct 31, 2016 |
Contact name |
Loris De Cecco |
E-mail(s) |
loris.dececco@istitutotumori.mi.it
|
Organization name |
IRCSS Istituto Nazionale Tumori
|
Street address |
via Venezian 1
|
City |
Milan |
ZIP/Postal code |
20133 |
Country |
Italy |
|
|
Platform ID |
GPL20968 |
Series (2) |
GSE73581 |
MiROvaR, a microRNA-based predictor of early relapse for ovarian cancer patients [training set; OC179] |
GSE73584 |
MiROvaR, a microRNA-based predictor of early relapse for ovarian cancer patients |
|